Launxp Biomedical Co (ROCO:6876) Research & Development: NT$50.64 Mil (TTM As of Dec. 2025)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$15.90
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co Research & Development?

Launxp Biomedical Co ROCO:6876 -0.93% 11 Research & Development is NT$50.64 Mil as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Launxp Biomedical Co's Research & Development for the six months ended in Dec. 2025 was NT$24.80 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$50.64 Mil.

Launxp Biomedical Co  (ROCO:6876) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Launxp Biomedical Co Research & Development Related Terms

Launxp Biomedical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co Research & Development Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 15.14 19.72 43.68 37.65 50.64

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 33.56 17.15 20.50 25.84 24.80
ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$50.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$50.64 Mil mean?
Launxp Biomedical Co (ROCO:6876) has a Research & Development of NT$50.64 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Launxp Biomedical Co and its competitors.
Is Launxp Biomedical Co's Research & Development too high?
Launxp Biomedical Co's current Research & Development is NT$50.64 Mil. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's Research & Development compare to VRTX and REGN?
Launxp Biomedical Co's Research & Development of NT$50.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Launxp Biomedical Co and its competitors. Launxp Biomedical Co's current Research & Development is NT$50.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current Research & Development of NT$50.64 Mil. The current Research & Development is NT$50.64 Mil. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current Research & Development is NT$50.64 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.90
Price